Jason earned his Ph.D. in Biomedical Engineering at The City College of New York, City University of New York in 2015. His dissertation focused on the validation and improvement of quantitative PET of atherosclerotic plaque metabolic activity using novel simultaneous PET/MR systems. Jason is currently using PET imaging to investigate mechanisms of disease and receptor/enzyme pharmacology in metabolic diseases, such as diabetes and obesity. Current projects include using PET to image dopamine in the pancreas both in type 1 and type 2 diabetes; whole-body distribution of the cortisol activating enzyme (11beta-hydroxysteroid dehydrogenase type 1); and method development (image reconstruction, attenuation and scatter correction) for whole-body kinetic modeling of novel PET radioligands in clinical and preclinical studies.
|First Place in General Clinical Specialties||Society for Nuclear Medicine||2022|